NFE2L2 and lung carcinoma: Datta and Sinha [208] investigated the role of EGCG against A549 lung cancer cells and observed inhibition of tumor cell growth by a decrease in the Nrf2 signaling pathway and increase in the oxidative stress in tumor cells at a concentration of 20–300 μM.